|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cuzick J, Thorat MA, Andriole G, Brawley
OW, Brown PH, Culig Z, Eeles RA, Ford LG, Hamdy FC, Holmberg L, et
al: Prevention and early detection of prostate cancer. Lancet
Oncol. 15:e484–e492. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Heidenreich A, Bastian PJ, Bellmunt J,
Bolla M, Joniau S, van der Kwast T, Mason M, Matveev V, Wiegel T,
Zattoni F, et al: European Association of Urology: EAU guidelines
on prostate cancer. Part 1: Screening, diagnosis, and local
treatment with curative intent-update 2013. Eur Urol. 65:124–137.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sarkar A and Hochedlinger K: The sox
family of transcription factors: Versatile regulators of stem and
progenitor cell fate. Cell Stem Cell. 12:15–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
She ZY and Yang WX: SOX family
transcription factors involved in diverse cellular events during
development. Eur J Cell Biol. 94:547–563. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Castillo SD and Sanchez-Cespedes M: The
SOX family of genes in cancer development: Biological relevance and
opportunities for therapy. Expert Opin Ther Targets. 16:903–919.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Thu KL, Becker-Santos DD, Radulovich N,
Pikor LA, Lam WL and Tsao MS: SOX15 and other SOX family members
are important mediators of tumorigenesis in multiple cancer types.
Oncoscience. 1:326–335. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dai W, Tan X, Sun C and Zhou Q: High
expression of SOX2 is associated with poor prognosis in patients
with salivary gland adenoid cystic carcinoma. Int J Mol Sci.
15:8393–8406. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shao W, Chen H and He J: The role of SOX-2
on the survival of patients with non-small cell lung cancer. J
Thorac Dis. 7:1113–1118. 2015.PubMed/NCBI
|
|
10
|
Zhou D, Bai F, Zhang X, Hu M, Zhao G, Zhao
Z and Liu R: SOX10 is a novel oncogene in hepatocellular carcinoma
through Wnt/β-catenin/TCF4 cascade. Tumour Biol. 35:9935–9940.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
François M, Caprini A, Hosking B, Orsenigo
F, Wilhelm D, Browne C, Paavonen K, Karnezis T, Shayan R, Downes M,
et al: Sox18 induces development of the lymphatic vasculature in
mice. Nature. 456:643–647. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Duong T, Koltowska K, Pichol-Thievend C,
Le Guen L, Fontaine F, Smith KA, Truong V, Skoczylas R, Stacker SA,
Achen MG, et al: VEGFD regulates blood vascular development by
modulating SOX18 activity. Blood. 123:1102–1112. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wünnemann F, Kokta V, Leclerc S, Thibeault
M, McCuaig C, Hatami A, Stheneur C, Grenier JC, Awadalla P,
Mitchell GA, et al: Aortic dilatation associated with a de novo
mutation in the SOX18 gene: Expanding the clinical spectrum of
hypotrichosis-lymphedema-telangiectasia syndrome. Can J Cardiol.
32:135.e1–135.e7. 2016. View Article : Google Scholar
|
|
14
|
Saitoh T and Katoh M: Expression of human
SOX18 in normal tissues and tumors. Int J Mol Med. 10:339–344.
2002.PubMed/NCBI
|
|
15
|
Wang G, Wei Z, Jia H, Zhao W, Yang G and
Zhao H: Knockdown of SOX18 inhibits the proliferation, migration
and invasion of hepatocellular carcinoma cells. Oncol Rep.
34:1121–1128. 2015.PubMed/NCBI
|
|
16
|
Pula B, Kobierzycki C, Solinski D,
Olbromski M, Nowak-Markwitz E, Spaczynski M, Kedzia W, Zabel M and
Dziegiel P: SOX18 expression predicts response to platinum-based
chemotherapy in ovarian cancer. Anticancer Res. 34:4029–4037.
2014.PubMed/NCBI
|
|
17
|
Pula B, Olbromski M, Wojnar A,
Gomulkiewicz A, Witkiewicz W, Ugorski M, Dziegiel P and
Podhorska-Okolow M: Impact of SOX18 expression in cancer cells and
vessels on the outcome of invasive ductal breast carcinoma. Cell
Oncol. 36:469–483. 2013. View Article : Google Scholar
|
|
18
|
Petrovic I, Milivojevic M, Popovic J,
Schwirtlich M, Rankovic B and Stevanovic M: SOX18 is a novel target
gene of Hedgehog signaling in cervical carcinoma cell lines. PLoS
One. 10:e01435912015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hoeth M, Niederleithner H, Hofer-Warbinek
R, Bilban M, Mayer H, Resch U, Lemberger C, Wagner O, Hofer E,
Petzelbauer P, et al: The transcription factor SOX18 regulates the
expression of matrix metalloproteinase 7 and guidance molecules in
human endothelial cells. PLoS One. 7:e309822012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fontijn RD, Volger OL, Fledderus JO,
Reijerkerk A, de Vries HE and Horrevoets AJ: SOX-18 controls
endothelial-specific claudin-5 gene expression and barrier
function. Am J Physiol Heart Circ Physiol. 294:H891–H900. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sheng Z, Liu Y, Qin C, Liu Z, Yuan Y, Hu
F, Du Y, Yin H, Qiu X and Xu T: IgG is involved in the migration
and invasion of clear cell renal cell carcinoma. J Clin Pathol.
69:497–504. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tu K, Liu Z, Yao B, Xue Y, Xu M, Dou C,
Yin G and Wang J: BCL-3 promotes the tumor growth of hepatocellular
carcinoma by regulating cell proliferation and the cell cycle
through cyclin D1. Oncol Rep. 35:2382–2390. 2016.PubMed/NCBI
|
|
23
|
Lee HR, Mitra J, Lee S, Gao SJ, Oh TK, Kim
MH, Ha T and Jung JU: Kaposi's sarcoma-associated herpesvirus viral
interferon regulatory factor 4 (vIRF4) perturbs the G1-S
cell cycle progression via deregulation of the cyclin D1 gene. J
Virol. 90:1139–1143. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Casimiro MC, Di Sante G, Ju X, Li Z, Chen
K, Crosariol M, Yaman I, Gormley M, Meng H, Lisanti MP, et al:
Cyclin D1 promotes androgen-dependent DNA damage repair in prostate
cancer cells. Cancer Res. 76:329–338. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang Y, Gong LH, Zhang HQ, Du Q, You JF,
Tian XX and Fang WG: Extracellular ATP enhances in vitro invasion
of prostate cancer cells by activating Rho GTPase and upregulating
MMPs expression. Cancer Lett. 293:189–197. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Grindel BJ, Martinez JR, Pennington CL,
Muldoon M, Stave J, Chung LW and Farach-Carson MC:
Matrilysin/matrix metalloproteinase-7 (MMP7) cleavage of
perlecan/HSPG2 creates a molecular switch to alter prostate cancer
cell behavior. Matrix Biol. 36:64–76. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kato T, Fujita Y, Nakane K, Mizutani K,
Terazawa R, Ehara H, Kanimoto Y, Kojima T, Nozawa Y, Deguchi T, et
al: CCR1/CCL5 interaction promotes invasion of taxane-resistant PC3
prostate cancer cells by increasing secretion of MMPs 2/9 and by
activating ERK and Rac signaling. Cytokine. 64:251–257. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fan L, Peng G, Sahgal N, Fazli L, Gleave
M, Zhang Y, Hussain A and Qi J: Regulation of c-Myc expression by
the histone demethylase JMJD1A is essential for prostate cancer
cell growth and survival. Oncogene. 35:2441–2452. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mohammed MK, Shao C, Wang J, Wei Q, Wang
X, Collier Z, Tang S, Liu H, Zhang F, Huang J, et al: Wnt/β-catenin
signaling plays an ever-expanding role in stem cell self-renewal,
tumorigenesis and cancer chemoresistance. Genes Dis. 3:11–40. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhao T, Yang H, Tian Y, Xie Q, Lu Y, Wang
Y, Su N, Dong B, Liu X, Wang C, et al: SOX7 is associated with the
suppression of human glioma by HMG-box dependent regulation of
Wnt/β-catenin signaling. Cancer Lett. 375:100–107. 2016. View Article : Google Scholar : PubMed/NCBI
|
